Image

B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.

Investigating Enzyme Activity for Cancer Investigation

Recruiting
18 years and older
All
Phase 0
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the detection of localized cancer by measuring the activity of different glycosidase enzymes in patients' plasma. It focuses on breast, prostate, and pancreatic cancers.

The study evaluates a diagnostic method using volatile organic compounds to identify glycosidase presence through ethanol detection, with the purpose of improving non-invasive cancer diagnostics.

  • Who can participate: Adults with untreated localized breast, prostate, or pancreatic cancer, as well as adults without any cancer, are eligible. Participants must not be minors, pregnant, or under legal protection.
  • Study details: Participants will provide blood plasma samples for analysis. For cancer patients, samples are taken before and after surgery.
Print
Study details
    Breast Cancer
    Pancreatic Cancer
    Pulmonary Cancer
    Volatile Organic Compound
    Glycosidase Activity
    Probes
    Tumor Markers
    Biological

NCT07236177

Poitiers University Hospital

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.